Glucuronyl glucosamine glycan sulfate clinical trials
Also written Sulodexide, KRX-101 and vessel due f.
How each study uses glucuronyl glucosamine glycan sulfate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the glucuronyl glucosamine glycan sulfate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2007 | 2 |
| 2009 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 12
Keryx Biopharmaceuticals (3) · Centro Medico del Noroeste (1) · Clinedem (1) · St Joseph University, Beirut, Lebanon (1) · Ajou University School of Medicine (1) · Xijing Hospital (1) · Arianna Anticoagulazione Foundation (1) · Value Outcomes Ltd. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses glucuronyl glucosamine glycan sulfate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 17
- Sulodexide in Controlling the Recurrence of PsoriasisEnrolling by invitationPhase 3Xijing HospitalNCT06982196Written as SulodexideHow we know
- Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)RecruitingPhase 3Arianna Anticoagulazione FoundationNCT04257487Written as SulodexideHow we know
- Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower ExtremitiesRecruitingPhase 3Value Outcomes Ltd.NCT05005052Written as VesselHow we know
- Endothelial Protection in Convalescent COVID-19 PatientsTerminatedPhase 4Pirogov Russian National Research Medical UniversityNCT05252923Written as SulodexideHow we know
- Endothelial Protection in Post COVID-19 Patients With SulodexideCompletedPhase 3Centro Medico del NoroesteNCT05371925Written as SulodexideHow we know
- The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With SclerotherapyStatus unknownNot applicableChengdu University of Traditional Chinese MedicineNCT05654233Written as SulodexideHow we know
- Effect of Sulodexide in Overt Diabetic NephropathyTerminatedPhase 4Keryx BiopharmaceuticalsNCT00130312Written as SulodexideHow we know
- Suloexide in the Treatment of Early Stages of COVID-19CompletedPhase 2/3ClinedemNCT04483830Written as SulodexideHow we know
- Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT AloneStatus unknownPhase 3Alfa Wassermann TunisiaNCT03370705Written as SulodexideHow we know
- Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)WithdrawnPhase 4Steno Diabetes Center CopenhagenNCT03504566Written as SulodexideHow we know
- Effect of Sulodexide in Early Diabetic NephropathyCompletedPhase 3Keryx BiopharmaceuticalsNCT00130208Written as SulodexideHow we know
- Sulodexide Efficacy in Chronic Idiopathic Subjective TinnitusCompletedPhase 2St Joseph University, Beirut, LebanonNCT02737670Written as SulodexideHow we know
- Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and SulodexideTerminatedPhase 4Bama GeVe, S.L.U.NCT02512601Written as SulodexideHow we know
- Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong KongTerminatedPhase 3Keryx BiopharmaceuticalsNCT00462202Written as sulodexideHow we know
- Sulodexide Treatment in Patients With Dense Deposit DiseaseWithdrawnPhase 1University of IowaNCT00583427Written as SulodexideHow we know
- Diabetic Retinopathy Sulodexide StudyCompletedPhase 2Ajou University School of MedicineNCT01295775Written as sulodexideHow we know
- The Efficacy and Safety Study of Sulodexide in Filipino Diabetic Patients With Chronic Kidney DiseaseStatus unknownPhase 3Corbridge Group Philippines, Inc.NCT01000545Written as SulodexideHow we know
Codes
What other systems call glucuronyl glucosamine glycan sulfate · ClinicalTrials.gg INT002410
- MeSH (NLM) C007858glucuronyl glucosamine glycan sulfateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 75HGV0062CSULODEXIDEConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C007858 | glucuronyl glucosamine glycan sulfate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 75HGV0062C | SULODEXIDE | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.